PCSK9 and familial hypercholesterolemia: In case of extreme risk (previous cardiovascular events or multi-vessel disease, familial hypercholesterolemia), starting therapy straight away with statins, ezetimibe and a PCSK9 inhibitor may be considered [25,37].